NCT02772003 2026-04-13DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus InfectionNational Cancer Institute (NCI)Phase 1 Active not recruiting33 enrolled
NCT03491683 2026-03-19INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM)Inovio PharmaceuticalsPhase 1/2 Active not recruiting52 enrolled